Ki67 labelling index and p53 status indicate neoplastic nature of atypical lobular endocervical glandular hyperplasia (ALEGH): Correspondence

Histopathology

Volumn 55, Issue 3, 2009, Pages 362-364

  Mikami, Yoshiki ^a   Kojima, Atsumi ^b   Kiyokawa, Takako ^c   Manabe, Toshiaki ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b CHIBA UNIVERSITY HOSPITAL   (Japan)

^c EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53;

ATYPICAL LOBULAR ENDOCERVICAL GLANDULAR HYPERPLASIA; CELL NUCLEUS; CELL STRUCTURE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPLASIA; LABELING INDEX; LETTER; NUCLEOLUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE CERVIX TUMOR; UTERINE ENDOCERVIX;

ADENOCARCINOMA; FEMALE; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; PRECANCEROUS CONDITIONS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 69549108344     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2009.03346.x     Document Type: Letter

References (7)

1. Nucci MR, Clement PB, Young RH. Lobular endocervical glandular hyperplasia, not otherwise specified: a clinicopathologic analysis of thirteen cases of a distinctive pseudoneoplastic lesion and comparison with fourteen cases of adenoma malignum. Am. J. Surg. Pathol. 1999 23 886 891.
2. Mikami Y, Hata S, Melamed J et al. Lobular endocervical glandular hyperplasia is a metaplastic process with a pyloric gland phenotype. Histopathology 2001 39 364 372. (Pubitemid 32990087)
3. Mikami Y, Kiyokawa T, Hata S et al. Gastrointestinal immunophenotype in adenocarcinomas of the uterine cervix and related glandular lesions: a possible link between lobular endocervical glandular hyperplasia/pyloric gland metaplasia and 'adenoma malignum'. Mod. Pathol. 2004 17 962 972.
4. Kawauchi S, Kusuda T, Liu XP et al. Is lobular endocervical glandular hyperplasia a cancerous precursor of minimal deviation adenocarcinoma?: a comparative molecular-genetic and immunohistochemical study. Am. J. Surg. Pathol. 2008 32 1807 1815.
5. Zaino RJ. Symposium part I: adenocarcinoma in situ, glandular dysplasia, and early invasive adenocarcinoma of the uterine cervix. Int. J. Gynecol. Pathol. 2002 21 314 326.
6. Cina SJ, Richardson MS, Austin RM et al. Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix. Mod. Pathol. 1997 10 176 180.
7. Mittal K. Utility of proliferation-associated marker MIB-1 in evaluating lesions of the uterine cervix. Adv. Anat. Pathol. 1999 6 177 185.